Inflammatory disorders

Two new studies evaluate agents for treating ulcerative colitis

In the first clinical trial to evaluate two biologic therapies for moderate to severe ulcerative colitis (UC) head to head, Mount Sinai researchers found vedolizumab to be superior to adalimumab in a variety of measures. ...

Medications

Treating C. difficile infections: New purpose for an old drug?

Common in hospitals and nursing homes, Clostridioides difficile infection (CDI) is a major health threat, particularly for older patients. According to a 2015 study by the Centers for Disease Control and Prevention, in the ...

Diseases, Conditions, Syndromes

Risk for developing idiopathic pulmonary fibrosis up in IBD

Patients with inflammatory bowel disease (IBD), especially male patients, have an increased risk for development of idiopathic pulmonary fibrosis (IPF), according to a study published online Aug. 16 in the Journal of Gastroenterology ...

Health

Finding an effective way to reduce pressure ulcers

Expensive high-tech air mattresses are only marginally better at preventing pressure sores and ulcers than a specialist foam mattress, according to the results of a major study.

Diabetes

Type 2 diabetes risk up with inflammatory bowel disease

(HealthDay)—Patients with inflammatory bowel disease (IBD) have increased risk of type 2 diabetes, according to a study published online Aug. 5 in Clinical Gastroenterology and Hepatology.

Diseases, Conditions, Syndromes

The impacts of smoking on patients with ulcerative colitis

Because smokers are less likely to develop ulcerative colitis (UC), a type of inflammatory bowel disease, patients with UC may be tempted to start smoking to lessen their symptoms. Researchers found no beneficial effects ...

page 34 from 40